Axon Enterprise, Inc $AXON Shares Acquired by Quest 10 Wealth Builders Inc.

Key Points

• Quest 10 Wealth Builders increased its Axon stake by 25,129.4% in the third quarter, ending with 4,289 shares valued at about $1.81 million.
• Axon’s third-quarter revenue rose 27.8% year over year to $908.6 million, but revenue and EPS of $1.72 fell short of analyst estimates. Its revenue outlook also trailed consensus expectations.
• Analysts maintain a “Moderate Buy” consensus rating, with an average price target of $688.38; company insiders sold 37,397 shares worth about $21.2 million over the past 90 days.

Quest 10 Wealth Builders Inc. lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 25,129.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,289 shares of the biotechnology company's stock after purchasing an additional 4,272 shares during the quarter. Axon Enterprise comprises approximately 1.3% of Quest 10 Wealth Builders Inc.'s portfolio, making the stock its 17th biggest position. Quest 10 Wealth Builders Inc.'s holdings in Axon Enterprise were worth $1,812,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Keating Financial Advisory Services Inc. purchased a new position in Axon Enterprise in the 2nd quarter valued at $31,000. Washington Trust Advisors Inc. raised its position in Axon Enterprise by 1,300.0% during the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company's stock worth $39,000 after buying an additional 65 shares during the last quarter. M & L Capital Management Ltd acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth $30,000. Wealth Enhancement Trust Services Inc. acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth $33,000. Finally, Delos Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter worth $45,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insider Activity at Axon Enterprise

In related news, insider Isaiah Fields sold 1,017 shares of the business's stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the sale, the insider owned 56,264 shares of the company's stock, valued at approximately $27,032,038.80. The trade was a 1.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the company's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the transaction, the president owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 37,397 shares of company stock worth $21,234,034 in the last ninety days. Corporate insiders own 4.20% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Piper Sandler lowered their target price on shares of Axon Enterprise from $732.00 to $561.00 and set an "overweight" rating on the stock in a report on Tuesday, October 20th. The Goldman Sachs Group cut their price target on shares of Axon Enterprise from $715.00 to $675.00 and set a "buy" rating for the company in a report on Monday, September 21st. UBS Group raised their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a research report on Thursday, August 6th. TD Cowen reduced their price objective on shares of Axon Enterprise from $825.00 to $800.00 and set a "buy" rating for the company in a research report on Monday, October 26th. Finally, Raymond James Financial set a $675.00 price objective on Axon Enterprise in a report on Thursday, October 15th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average target price of $688.38.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $382.56 on Friday. The firm has a market capitalization of $31.08 billion, a P/E ratio of 158.74, a PEG ratio of 8.06 and a beta of 1.48. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $665.07. The company's fifty day moving average is $447.49 and its two-hundred day moving average is $476.73. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). The company had revenue of $908.55 million during the quarter, compared to analysts' expectations of $934.33 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business's revenue for the quarter was up 27.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.17 EPS. Analysts forecast that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.